IgD Mab Technology (IMT) – IMT is a privately held Australian biotechnology startup company that focuses on the clinical & commercial development of therapeutic anti-IgD monoclonal antibody (mAb) into a new innovative and advanced disease-modifying mAb treatment for human autoimmune diseases, allergic skin inflammations and B-CLL.
Description
IMT is a privately held Australian biotechnology startup company that focuses on the clinical & commercial development of therapeutic anti-IgD monoclonal antibody (mAb) into a new innovative and advanced disease-modifying mAb treatment for human autoimmune diseases, allergic skin inflammations and B-CLL.
Server
nginx
DNS
View domain name system records, including the A, AAAA, MX and NS records.